Indivior PLC Logo

Indivior PLC

Pharmaceutical company developing medicines for substance use and mental disorders.

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+2 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH

Description

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-01-02 08:00
Transaction in Own Shares
English 103.4 KB
2023-12-29 08:00
Transaction in Own Shares
English 211.2 KB
2023-12-28 08:00
Transaction in Own Shares
English 162.1 KB
2023-12-27 08:00
Transaction in Own Shares
English 179.0 KB
2023-12-22 13:42
Holding(s) in Company
English 22.8 KB
2023-12-22 12:46
Holding(s) in Company
English 21.3 KB
2023-12-22 08:00
Transaction in Own Shares
English 177.9 KB
2023-12-21 11:33
Director/PDMR Shareholding
English 16.3 KB
2023-12-21 08:00
Transaction in Own Shares
English 163.3 KB
2023-12-20 08:00
Indivior Settles Patent Dispute with Actavis
English 8.0 KB
2023-12-20 08:00
Transaction in Own Shares
English 245.8 KB
2023-12-19 08:00
Transaction in Own Shares
English 230.6 KB
2023-12-18 08:00
Transaction in Own Shares
English 299.9 KB
2023-12-15 08:00
Transaction in Own Shares
English 177.3 KB
2023-12-14 08:00
Transaction in Own Shares
English 309.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Indivior PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.